Free Trial

Hims & Hers Health (HIMS) Competitors

Hims & Hers Health logo
$56.80 +0.47 (+0.83%)
Closing price 06/9/2025 03:59 PM Eastern
Extended Trading
$56.70 -0.10 (-0.18%)
As of 08:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIMS vs. NTRA, FMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, and CON

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

Hims & Hers Health vs.

Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation, community ranking and profitability.

Hims & Hers Health presently has a consensus target price of $38.00, suggesting a potential downside of 33.10%. Natera has a consensus target price of $184.63, suggesting a potential upside of 12.45%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
Natera
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
3.00

Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.78B7.13-$23.55M$0.6982.32
Natera$1.83B12.24-$434.80M-$1.47-111.69

In the previous week, Hims & Hers Health had 28 more articles in the media than Natera. MarketBeat recorded 45 mentions for Hims & Hers Health and 17 mentions for Natera. Natera's average media sentiment score of 0.84 beat Hims & Hers Health's score of 0.77 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
25 Very Positive mention(s)
8 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Natera
11 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Natera received 448 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.90% of users gave Natera an outperform vote while only 35.38% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
46
35.38%
Underperform Votes
84
64.62%
NateraOutperform Votes
494
68.90%
Underperform Votes
223
31.10%

Hims & Hers Health has a beta of 2.09, suggesting that its share price is 109% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500.

Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
Natera -14.01%-26.23%-14.27%

Summary

Hims & Hers Health and Natera tied by winning 9 of the 18 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIMS vs. The Competition

MetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$12.71B$1.79B$5.51B$19.72B
Dividend YieldN/AN/A5.27%3.85%
P/E Ratio129.0928.0027.1735.75
Price / Sales7.131.74410.8445.92
Price / CashN/A36.0138.2517.51
Price / Book35.2818.026.964.82
Net Income-$23.55M-$52.07M$3.23B$1.02B
7 Day Performance3.68%-0.89%5.25%1.56%
1 Month Performance9.15%17.85%14.01%5.05%
1 Year Performance162.78%77.07%32.31%13.96%

Hims & Hers Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIMS
Hims & Hers Health
2.4932 of 5 stars
$56.80
+0.8%
$38.00
-33.1%
+173.2%$12.71B$1.78B129.09650Analyst Downgrade
Insider Trade
NTRA
Natera
2.1918 of 5 stars
$165.10
+0.8%
$184.63
+11.8%
+47.7%$22.54B$1.83B-93.803,020
FMS
Fresenius Medical Care
2.6331 of 5 stars
$28.65
+0.5%
$27.80
-3.0%
+34.1%$16.81B$19.49B23.68123,200
GH
Guardant Health
3.2898 of 5 stars
$50.32
+4.7%
$53.29
+5.9%
+72.8%$6.23B$774.00M-14.131,790Trending News
Insider Trade
OPCH
Option Care Health
4.1145 of 5 stars
$31.68
-0.7%
$35.50
+12.1%
+8.5%$5.19B$5.19B26.635,600Positive News
RDNT
RadNet
3.5613 of 5 stars
$58.82
+0.3%
$69.75
+18.6%
-3.6%$4.42B$1.87B-842.028,970
BTSG
BrightSpring Health Services
0.7904 of 5 stars
$23.82
-1.2%
$23.56
-1.1%
+117.9%$4.15B$11.86B-91.6035,000Gap Up
SHC
Sotera Health
2.7272 of 5 stars
$12.46
+1.3%
$15.80
+26.9%
+1.5%$3.54B$1.11B49.903,000Positive News
Analyst Downgrade
SGRY
Surgery Partners
2.8791 of 5 stars
$23.17
-0.1%
$33.56
+44.8%
-8.2%$2.97B$3.17B-48.2712,200
PRVA
Privia Health Group
3.4093 of 5 stars
$23.30
+0.5%
$27.77
+19.2%
+35.5%$2.84B$1.80B233.01810
CON
Concentra Group Holdings Parent
N/A$22.14
+0.5%
$28.50
+28.7%
N/A$2.82B$1.93B16.5211,000Positive News

Related Companies and Tools


This page (NYSE:HIMS) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners